Highnoon Laboratories reports Q3 2026 results; quarterly profit and EPS decline year over year
Financial ResultThe board approved Highnoon Laboratories’ financial results for the quarter ended September 30, 2026. In the unconsolidated quarterly figures, profit after tax and EPS were lower than in the comparable quarter, while revenue and profit from operations increased. No cash dividend, bonus shares, rights shares, or other corporate action was recommended.
Payout
- No cash dividend
Key Findings
- Quarterly unconsolidated profit after tax was Rs. 943.6 million, down from Rs. 1,001.1 million in the comparable quarter.
- EPS declined to Rs. 17.81 from Rs. 18.89.
- Quarterly revenue was Rs. 6,617.0 million; profit from operations was Rs. 1,613.7 million.
- The board recommended NIL cash dividend, bonus shares, rights shares, and other entitlement/corporate action.
Financial Performance
| Metric | PreviousQuarter ended September 30, 2025 | CurrentQuarter ended September 30, 2026 | Change |
|---|---|---|---|
| Revenue from contracts with customers - net | - | 6,617,015,900 | - |
| Gross profit | - | 3,683,980,799 | - |
| Profit from operations | - | 1,613,732,059 | - |
| Profit after tax for the period | 1,001,079,479 | 943,615,723 | -5.7% |
| Earnings per share - basic and diluted (Rupees) | 18.89 | 17.81 | -5.7% |
| Finance cost | - | (26,499,748) | - |
| Cash and bank balances | 468,796,488 | 842,994,828 | +79.8% |
| Long-term loan - secured | 2,423,493 | 231,956,795 | +9,471.2% |
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.
